Entera Bio (ENTX) Deferred Taxes (2021 - 2024)

Entera Bio (ENTX) has reported Deferred Taxes for 4 consecutive years, with $14000.0 the latest figure, recorded in Q4 2024.

• Quarterly Deferred Taxes changed N/A year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (up 48.28% YoY) and the FY2024 annual result came in at $14000.0, down 51.72% from the prior year.
• Deferred Taxes retreated to $14000.0 in Q4 2024 per ENTX's latest filing, from $29000.0 in the prior quarter.
• Over the last five years, Deferred Taxes for ENTX reached as high as $214000.0 in Q3 2022 and fell as low as -$57000.0 in Q2 2021.
• A 4-year average of $0.0 and a median of -$31500.0 in 2022 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2022 — Deferred Taxes jumped 475.44% — and 2023, when it slumped 86.45%.
• Year by year, Deferred Taxes stood at -$51000.0 in 2021, then soared by 145.1% to $23000.0 in 2022, then climbed by 26.09% to $29000.0 in 2023, then tumbled by 51.72% to $14000.0 in 2024.
• According to Business Quant data, Deferred Taxes over the past three periods registered $14000.0, $29000.0, and $23000.0 for Q4 2024, Q3 2023, and Q4 2022 respectively.